Neoadjuvant chemotherapy in patients with advanced endometrial cancer

ConclusionsUnlike ovarian cancer, less than half of the patients undergoing NACT for endometrial cancer underwent IDS, none had a complete response, and 41% had disease progression during NACT. However, endometrial cancer patients who underwent IDS had a high rate of optimal cytoreduction. Both response to NACT and IDS were associated with improved survival.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research